Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction
about
Inflammatory and oxidative stress in rotavirus infectionSmart nanosystems: Bio-inspired technologies that interact with the host environmentPoxvirus cell entry: how many proteins does it take?Protein disulfide isomerase and host-pathogen interactionProtein disulfide isomerase a multifunctional protein with multiple physiological rolesDecoding protein networks during virus entry by quantitative proteomicsAcid-resistant bovine pestivirus requires activation for pH-triggered fusion during entry.Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered EntrySecretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitroThe molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replicationCharacterization of the estradiol-binding site structure of human protein disulfide isomerase (PDI)The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry InhibitionViral envelope protein folding and membrane hemifusion are enhanced by the conserved loop region of HIV-1 gp41.Bacitracin reveals a role for multiple thiol isomerases in platelet function.Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate.Protein disulfide isomerase, a component of the estrogen receptor complex, is associated with Chlamydia trachomatis serovar E attached to human endometrial epithelial cellsProtein disulfide isomerase of Toxoplasma gondii is targeted by mucosal IgA antibodies in humans.Thrombocytopenia in patients with severe acute respiratory syndrome (review).Molecular docking studies of dithionitrobenzoic acid and its related compounds to protein disulfide isomerase: computational screening of inhibitors to HIV-1 entry.Attachment and entry of Chlamydia have distinct requirements for host protein disulfide isomerase.Disulfide reduction in CD4 domain 1 or 2 is essential for interaction with HIV glycoprotein 120 (gp120), which impairs thioredoxin-driven CD4 dimerizationActivity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe.Thiol isomerases in thrombus formation.Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomeraseCell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide.Bacitracin inhibits the reductive activity of protein disulfide isomerase by disulfide bond formation with free cysteines in the substrate-binding domain.Applying small molecule microarrays and resulting affinity probe cocktails for proteome profiling of mammalian cell lysates.Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchangeBacitracin is not a specific inhibitor of protein disulfide isomerase.Identification of a disulfide isomerase protein of Leishmania major as a putative virulence factor.Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infectionDisulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxinReducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanismEfficient replication of a paramyxovirus independent of full zippering of the fusion protein six-helix bundle domain.Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteinsNeutrophils Turn Plasma Proteins into Weapons against HIV-1.Lymphocyte surface thiol levels.Proteins of the PDI family: unpredicted non-ER locations and functions.Sensitivity of human immunodeficiency virus to bicyclam derivatives is influenced by the three-dimensional structure of gp120.Discovery of protein disulfide isomerase P5 inhibitors that reduce the secretion of MICA from cancer cells.
P2860
Q26749801-8A34BD55-A51E-4EAA-ADBE-A674D221C715Q26776370-2E4B85ED-EDF5-41FA-AE26-0727F1DD837DQ27002455-00641E6B-37A9-422B-94CA-D71A5788E918Q27005875-B6C0B6E2-E03B-4B99-8E7B-525B530F09ADQ27022009-359EBD4C-61D3-414D-B026-DEDD722F5BCDQ27469058-917C9EC2-A220-4DA1-958D-F34B32479CD8Q27469429-6DB3D1F1-5881-430A-A9C3-B4898EF0F7D7Q27472926-1F91FD34-C51A-4429-9AA0-7A4CB0D27466Q28293679-A1FEB12B-CB4B-4DF9-BB0C-0E3D3FB3522FQ28378759-FA9B2243-D5D6-4105-A771-FCEEC0C5067DQ28477788-8DB09A47-CF00-4D58-BC3A-FC2A164A0E76Q28552932-B5588818-A223-4D40-AAE3-2A308E710A49Q30426201-C0F9359F-8A65-4466-881C-BA83390B28BBQ30806590-BD503DD1-899C-49A5-AF13-23670994BCF9Q30894431-CF9D6DCA-ED48-4E4F-83C1-0E06B8C03CDCQ31078384-ACEEEF4F-AAE5-4BD4-B78C-899574CB83FAQ32147854-ECDB807D-1965-4028-950B-10A454C1BB7FQ33367297-A58631C3-30D4-4CCA-AD1E-56781B0C6671Q33393930-FF41240A-FA84-4D82-A908-B5D38668161EQ33426342-1C5CF366-16FA-4C02-9D95-B72E427C5BE9Q33675700-B8663C44-C080-467F-95DD-C6D515522B7AQ33704103-0B7941D7-2A43-4C95-AA61-3AE4AA6D2339Q33792729-C2CE2682-B5FE-481B-A271-527C0EB7E5DFQ33810106-FD30E6EB-C9C6-4D68-B868-C47F1907A42CQ33835861-F4B1B956-F6B2-46DB-A8F3-CC2CD5211C2CQ33868087-750CE817-B412-4AE2-BC49-4CADF97AED28Q34013178-BC80225F-174F-4BBC-A625-3625466C0555Q34055984-2FC09B5B-1808-4849-8352-1C596EEE85A9Q34115847-915BA16B-6A4A-4B5C-BDEB-3160E36422B7Q34126878-0E96F8C7-5EF5-4F9A-A0FD-2D0C3A89BCD7Q34315133-FD099465-8430-4C7B-B2C6-5A04EE3164DBQ34401027-32BF5E0D-61E4-4363-B2D9-D0DC2E3351FFQ34543854-FF5D6277-96E1-4E17-8F96-B2704939271CQ34583532-6FCC8865-6B42-4EDC-8BC6-A588A6538030Q34651454-48F04922-FBEC-4235-B16E-79600E4F0836Q34804975-1D7395D4-7E14-48EF-A4FC-1B0D50B73028Q34920137-AF755EEB-1045-4047-A04D-847733941BCFQ34972858-BA54825B-20DA-4902-9CC7-201C9AA09A2CQ35139301-5823FF11-ED25-4AF3-9C83-81E2857BDB80Q35185798-4901990B-CEA0-40E6-91A0-88E454EADEBC
P2860
Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Inhibition of human immunodefi ...... pon virus-receptor interaction
@ast
Inhibition of human immunodefi ...... pon virus-receptor interaction
@en
Inhibition of human immunodefi ...... pon virus-receptor interaction
@nl
type
label
Inhibition of human immunodefi ...... pon virus-receptor interaction
@ast
Inhibition of human immunodefi ...... pon virus-receptor interaction
@en
Inhibition of human immunodefi ...... pon virus-receptor interaction
@nl
prefLabel
Inhibition of human immunodefi ...... pon virus-receptor interaction
@ast
Inhibition of human immunodefi ...... pon virus-receptor interaction
@en
Inhibition of human immunodefi ...... pon virus-receptor interaction
@nl
P2093
P2860
P356
P1476
Inhibition of human immunodefi ...... pon virus-receptor interaction
@en
P2093
P2860
P304
P356
10.1073/PNAS.91.10.4559
P407
P577
1994-05-10T00:00:00Z